Kunshan RiboQuark Pharmaceutical Technology Co
Latest round
- Series A
Last raised
- Dec 2013
Total raised
- $7.4M
Investors
- 4
About Kunshan RiboQuark Pharmaceutical Technology Co
Founded in 2012 and based in Kunshan, China, Kunshan RiboQuark Pharmaceutical Technology Co operates as a clinical stage pharmaceutical company. The firm is jointly established by Suzhou Ribo Life Science and Quark Pharmaceuticals. The company's main product is the ophthalmic drug QPI-1007. QPI-1007 is used to treat eye diseases such as non-arteritic anterior ischemic optic neuropathy and acute angle-closure glaucoma. The company’s revenue is generated by providing ophthalmic drugs.
Who invested in Kunshan RiboQuark Pharmaceutical Technology Co
4 investors across 1 round
See all investors in Kunshan RiboQuark Pharmaceutical Technology Co
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 31, 2013
Amount
$7.4M
Investors
Questions about Kunshan RiboQuark Pharmaceutical Technology Co
Who invested in Kunshan RiboQuark Pharmaceutical Technology Co?
Kunshan RiboQuark Pharmaceutical Technology Co has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kunshan RiboQuark Pharmaceutical Technology Co raised?
Kunshan RiboQuark Pharmaceutical Technology Co has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kunshan RiboQuark Pharmaceutical Technology Co last raise money?
Kunshan RiboQuark Pharmaceutical Technology Co's most recent round on record is a Series A, in Dec 2013.
What does Kunshan RiboQuark Pharmaceutical Technology Co do?
Founded in 2012 and based in Kunshan, China, Kunshan RiboQuark Pharmaceutical Technology Co operates as a clinical stage pharmaceutical company.
Where is Kunshan RiboQuark Pharmaceutical Technology Co headquartered?
Kunshan RiboQuark Pharmaceutical Technology Co is headquartered in Kunshan, China.
Which VCs invest in companies like Kunshan RiboQuark Pharmaceutical Technology Co?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Kunshan RiboQuark Pharmaceutical Technology Co's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Kunshan RiboQuark Pharmaceutical Technology Co? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.